Though the trial demonstrates the feasibility of the approach, future research is needed to assess the clinical impact.
The dual approach, though rare, was linked to fewer 2-year MACE and lower long-term costs compared with angiography alone.
Cardio-oncologists should incorporate vascular prevention in their care, especially for those without protective hormones.
With COVID now out of the top 5, stroke has taken over the number 4 position thanks to rising death rates in young and old.
Taking into account estimated 30-year risk of atherosclerotic cardiovascular disease (ASCVD) enables clinicians to identify ...
For example, in the CTO setting, “IVUS can facilitate proximal cap puncture, subintimal navigation, and reentry, whereas OCT ...
The risks of in-hospital complications and mortality at 30 days were significantly higher in patients with severe aortic ...
The initiation of patient enrolment in the STARS DAPT trial marks an important milestone for Abluminus np. While contemporary ...
Michelle O'Donoghue rejoins Roxana Mehran to kick off 2026 with thoughts on dietary guidelines, prevention, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results